Drugs Health Pharma

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

Read More
Climate Health Pharma

Days getting longer as ice melts cause a shift in Earth’s mass, impacting rotation

Climate change is making days longer by a few milliseconds as the ice melts in Antarctica and Greenland is causing a shift in.

Read More
Drugs Health Pharma

FDA declines approval for Novo Nordisk’s diabetic medicine

Novo Nordisk, has been denied approval for its type 1 diabetic medicine by the USFDA, according to the Danish drugmaker.

Read More
Drugs Health Pharma

Global health body prequalifies OraQuick’s hepatitis C virus self-test

OraSure Technologies’ hepatitis C virus self-test has been prequalified by the World Health Organization in a global bid to eliminate the disease.

Read More
Drugs Health Pharma

Pharmacy benefit managers in the US wielding ‘enormous power’: FTC report

Pharmacy benefit managers, who handle about 95% of US prescriptions, are inflating drug costs and squeezing independent pharmacies, according to a report.

Read More
Drugs Health Pharma

Diet, exercise, socialisation may help in early stage Alzheimer’s disease

Intensive diet and lifestyle changes may forestall a cognitive decline in Alzheimer’s disease and make progress for patients during early stages, a study.

Read More
Climate Health Pharma

Heat, cold may affect development of brain in children: ISGlobal

Children are vulnerable to temperature changes as their thermoregulation mechanisms are still immature, a study reveals.

Read More
Drugs Medical Pharma

Thermo Fisher’s $3.1 billion buy of Olink gets UK competition regulators’ nod

Antitrust regulators in the UK have cleared a $3.1 billion acquisition of Olink Holding AB by Thermo Fisher Scientific Inc., following an initial.

Read More
Drugs Health Pharma

Eli Lilly to buy Morphic for $3.2 b in cash to expand integrin therapies

Eli Lilly and Company will acquire biopharmaceutical firm, Morphic Holding Inc., for $3.2 billion in cash, giving it access to a molecule inhibitor.

Read More
Drugs Health Opinion Pharma

Opinion: West Nile Virus’ genetic sequence needs in-depth study

Urgent steps are needed to study the dynamics of the circulating viral strains about its vector, hosts and environment for developing effective preventive.

Read More